IRIDEX Corporation (IRIX)
USD 0.88
(-7.25%)
USD 0.88
(-7.25%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.75 Million USD | 139.21% |
| 2022 | 732 Thousand USD | -57.66% |
| 2021 | 1.72 Million USD | 13.01% |
| 2020 | 1.53 Million USD | -14.76% |
| 2019 | 1.79 Million USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| 2016 | - USD | 0.0% |
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| 1999 | - USD | 0.0% |
| 1998 | - USD | 0.0% |
| 1997 | - USD | 0.0% |
| 1996 | - USD | 0.0% |
| 1995 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | 1.52 Million USD | -100.0% |
| 2024 Q2 | 1.29 Million USD | 0.0% |
| 2023 Q4 | 1.75 Million USD | -7.89% |
| 2023 Q2 | 210 Thousand USD | -55.51% |
| 2023 Q1 | 472 Thousand USD | -35.52% |
| 2023 Q3 | 1.9 Million USD | 805.24% |
| 2023 FY | 1.75 Million USD | 139.21% |
| 2022 FY | 732 Thousand USD | -57.66% |
| 2022 Q1 | 1.47 Million USD | -14.46% |
| 2022 Q2 | 1.22 Million USD | -17.38% |
| 2022 Q3 | 961 Thousand USD | -21.36% |
| 2022 Q4 | 732 Thousand USD | -23.83% |
| 2021 Q1 | 407 Thousand USD | -73.4% |
| 2021 Q4 | 1.72 Million USD | -12.32% |
| 2021 FY | 1.72 Million USD | 13.01% |
| 2021 Q3 | 1.97 Million USD | -7.68% |
| 2021 Q2 | 2.13 Million USD | 424.82% |
| 2020 Q3 | 1.58 Million USD | -35.36% |
| 2020 FY | 1.53 Million USD | -14.76% |
| 2020 Q1 | 1.43 Million USD | -20.0% |
| 2020 Q2 | 2.45 Million USD | 70.96% |
| 2020 Q4 | 1.53 Million USD | -3.59% |
| 2019 Q2 | 2.51 Million USD | -12.27% |
| 2019 FY | 1.79 Million USD | 0.0% |
| 2019 Q4 | 1.79 Million USD | -16.55% |
| 2019 Q3 | 2.15 Million USD | -14.51% |
| 2019 Q1 | 2.86 Million USD | 0.0% |
| 2018 Q3 | - USD | 0.0% |
| 2018 Q4 | - USD | 0.0% |
| 2018 Q2 | - USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2018 Q1 | - USD | 0.0% |
| 2017 Q1 | - USD | 0.0% |
| 2017 Q3 | - USD | 0.0% |
| 2017 Q4 | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q1 | - USD | 0.0% |
| 2016 FY | - USD | 0.0% |
| 2016 Q4 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2001 Q2 | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q1 | - USD | 0.0% |
| 2000 Q4 | - USD | 0.0% |
| 2000 Q1 | - USD | 0.0% |
| 2000 Q2 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| 1999 Q1 | - USD | 0.0% |
| 1999 FY | - USD | 0.0% |
| 1999 Q2 | - USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 Q4 | - USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1998 FY | - USD | 0.0% |
| 1998 Q1 | - USD | 0.0% |
| 1998 Q2 | - USD | 0.0% |
| 1998 Q4 | - USD | 0.0% |
| 1997 FY | - USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q4 | - USD | 0.0% |
| 1996 Q3 | - USD | 0.0% |
| 1996 Q4 | - USD | 0.0% |
| 1996 FY | - USD | 0.0% |
| 1996 Q2 | - USD | 0.0% |
| 1995 Q4 | - USD | 0.0% |
| 1995 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 36.1 Million USD | 95.15% |
| BrainsWay Ltd. | 239 Thousand USD | -632.636% |
| Cerus Corporation | 59.79 Million USD | 97.072% |
| Envoy Medical, Inc. | 404 Thousand USD | -333.416% |
| electroCore, Inc. | 537 Thousand USD | -226.071% |
| Helius Medical Technologies, Inc. | 12 Thousand USD | -14491.667% |
| IceCure Medical Ltd | 376 Thousand USD | -365.691% |
| Inogen, Inc. | 18.27 Million USD | 90.416% |
| OrthoPediatrics Corp. | 13.45 Million USD | 86.99% |
| Lucid Diagnostics Inc. | 199 Thousand USD | -779.899% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | -381.409% |
| MaxCyte, Inc. | 17.96 Million USD | 90.255% |
| NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -3067.282% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| Orthofix Medical Inc. | 93.1 Million USD | 98.119% |
| PAVmed Inc | 2.96 Million USD | 40.845% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | 71.822% |
| RxSight, Inc. | 1.21 Million USD | -44.591% |
| Sight Sciences, Inc. | 31.7 Million USD | 94.478% |
| SI-BONE, Inc. | 36.06 Million USD | 95.145% |
| TELA Bio, Inc. | 40.51 Million USD | 95.678% |
| Treace Medical Concepts, Inc. | 53 Million USD | 96.697% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | -15.122% |
| Acutus Medical, Inc. | 32.65 Million USD | 94.638% |
| Talis Biomedical Corporation | 16.78 Million USD | 89.569% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Nano-X Imaging Ltd. | 4.04 Million USD | 56.712% |
| CVRx, Inc. | 30.38 Million USD | 94.237% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 1.01 Million USD | -72.185% |
| Bioventus Inc. | 366.99 Million USD | 99.523% |
| Venus Concept Inc. | 70.79 Million USD | 97.526% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | -40.756% |
| LivaNova PLC | 568.54 Million USD | 99.692% |
| 908 Devices Inc. | 3.92 Million USD | 55.434% |
| Alphatec Holdings, Inc. | 511.03 Million USD | 99.657% |
| Nemaura Medical Inc. | 3.08 Million USD | 43.29% |
| NeuroPace, Inc. | 56.95 Million USD | 96.926% |
| LENSAR, Inc. | 1.75 Million USD | -0.057% |
| Apyx Medical Corporation | 33.18 Million USD | 94.724% |
| Cutera, Inc. | 418.69 Million USD | 99.582% |
| STRATA Skin Sciences, Inc. | 15.04 Million USD | 88.361% |
| BioSig Technologies, Inc. | 103 Thousand USD | -1600.0% |
| Anika Therapeutics, Inc. | 26.9 Million USD | 93.492% |
| ClearPoint Neuro, Inc. | 9.94 Million USD | 82.4% |
| Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 99.882% |
| Axonics, Inc. | 25.84 Million USD | 93.224% |
| Outset Medical, Inc. | 134.59 Million USD | 98.699% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | 96.589% |
| IRadimed Corporation | 1.61 Million USD | -8.416% |
| Tivic Health Systems, Inc. | 176 Thousand USD | -894.886% |
| INVO Bioscience, Inc. | 6.77 Million USD | 74.159% |
| Telesis Bio, Inc. | 5.26 Million USD | 66.768% |
| Viemed Healthcare, Inc. | 5.97 Million USD | 70.676% |
| Varex Imaging Corporation | 464.2 Million USD | 99.623% |
| Quipt Home Medical Corp. | 60.82 Million USD | 97.121% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -197.789% |
| Pulmonx Corporation | 35.08 Million USD | 95.01% |
| Dynatronics Corporation | 3.25 Million USD | 46.263% |
| Modular Medical, Inc. | 817 Thousand USD | -114.321% |
| ReShape Lifesciences Inc. | 151 Thousand USD | -1059.603% |
| Semler Scientific, Inc. | 70 Thousand USD | -2401.429% |
| InMode Ltd. | 6.61 Million USD | 73.522% |
| Bruker Corporation | 1.14 Billion USD | 99.847% |
| Cytosorbents Corporation | 2.54 Million USD | 31.14% |
| DexCom, Inc. | 2.57 Billion USD | 99.932% |
| Align Technology, Inc. | 96.96 Million USD | 98.194% |
| Viveve Medical, Inc. | 5.12 Million USD | 65.827% |
| ZimVie Inc. | 508.79 Million USD | 99.656% |
| Movano Inc. | 15.00 USD | -11673233.333% |
| Cytek Biosciences, Inc. | 18.12 Million USD | 90.339% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | 99.561% |
| Profound Medical Corp. | 4.97 Million USD | 64.8% |
| Insulet Corporation | 1.36 Billion USD | 99.872% |
| enVVeno Medical Corporation | 1.06 Million USD | -64.568% |
| Surmodics, Inc. | 29.4 Million USD | 94.045% |
| iCAD, Inc. | 273 Thousand USD | -541.392% |
| Nuwellis, Inc. | 221 Thousand USD | -692.308% |
| Biotricity, Inc. | 10.85 Million USD | 83.87% |
| iRhythm Technologies, Inc. | 34.95 Million USD | 94.99% |
| Aethlon Medical, Inc. | 649.75 Thousand USD | -169.488% |
| InspireMD, Inc. | 1.03 Million USD | -68.69% |
| PAVmed Inc. | 2.96 Million USD | 40.845% |
| BIOLASE, Inc. | 13.98 Million USD | 87.479% |
| Beyond Air, Inc. | 14.72 Million USD | 88.105% |
| FONAR Corporation | 37.92 Million USD | 95.384% |
| AxoGen, Inc. | 46.6 Million USD | 96.243% |
| Vivani Medical, Inc. | 19.31 Million USD | 90.934% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | 96.075% |
| Inari Medical, Inc. | 30.35 Million USD | 94.232% |
| UFP Technologies, Inc. | 28 Million USD | 93.746% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | -303.414% |
| Tenon Medical, Inc. | 428 Thousand USD | -309.112% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -74.75% |
| Co-Diagnostics, Inc. | 2.15 Million USD | 18.641% |
| AdaptHealth Corp. | 2.09 Billion USD | 99.916% |
| Sintx Technologies, Inc. | 3.68 Million USD | 52.509% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Quanterix Corporation | 37.22 Million USD | 95.296% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -197.789% |
| Sensus Healthcare, Inc. | 596 Thousand USD | -193.792% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | 99.804% |
| TransMedics Group, Inc. | 506.2 Million USD | 99.654% |
| ReWalk Robotics Ltd. | 607 Thousand USD | -188.468% |
| NeuroMetrix, Inc. | 92.48 Thousand USD | -1793.28% |
| Hyperfine, Inc. | 64 Thousand USD | -2635.938% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | 99.072% |
| Biomerica, Inc. | 459 Thousand USD | -281.481% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -289.559% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | -821.642% |
| Silk Road Medical, Inc | 75.62 Million USD | 97.685% |